Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.21)
# 2,833
Out of 4,980 analysts
807
Total ratings
38.56%
Success rate
-1.98%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics | Reiterates: Buy | $47 | $25.70 | +82.91% | 4 | Sep 10, 2025 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $1.11 | +260.36% | 23 | Sep 2, 2025 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $5 | $1.30 | +284.62% | 18 | Sep 2, 2025 | |
| NEUP Neuphoria Therapeutics | Reiterates: Buy | $21 | $14.22 | +47.73% | 2 | Aug 26, 2025 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $138.88 | +72.81% | 33 | Aug 22, 2025 | |
| LSTA Lisata Therapeutics | Reiterates: Buy | $15 | $2.25 | +566.67% | 17 | Aug 21, 2025 | |
| FBIO Fortress Biotech | Maintains: Buy | $26 → $17 | $3.74 | +354.55% | 4 | Aug 21, 2025 | |
| CLDX Celldex Therapeutics | Maintains: Buy | $50 → $42 | $25.41 | +65.29% | 36 | Aug 20, 2025 | |
| PHGE BiomX | Reiterates: Buy | $15 | $0.48 | +3,057.89% | 16 | Aug 20, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $26.26 | +288.42% | 34 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.41 | +729.88% | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $7.64 | +109.42% | 21 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $9.63 | +211.53% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $6.50 | +53.85% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.32 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $77 → $24 | $6.31 | +280.35% | 24 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.21 | +974.38% | 32 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $14.67 | +186.30% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.42 | +478.51% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $53 | $64.72 | -18.11% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.66 | +140.96% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.29 | +597.67% | 12 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.38 | +955.41% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.76 | +480.76% | 29 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $5.09 | +17.88% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.96 | +556.57% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.05 | +387.80% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $5.49 | +537.52% | 9 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.75 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $36.33 | +186.30% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.03 | +197.16% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.89 | +799.47% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $13.58 | +135.64% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.42 | +367.84% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $11.84 | +2,011.49% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.73 | +1,132.88% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.91 | +844.88% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.27 | +383.68% | 26 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $3.54 | +577.97% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $52.36 | +129.18% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $10.84 | +47.60% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.22 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $6.35 | +388.19% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.63 | +636.20% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.86 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $14.88 | +148.59% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.61 | +583.23% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $37.25 | +53.02% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.60 | +1,150.00% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.18 | +1,046.79% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.98 | +738.93% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.53 | +6,435.95% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.91 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $0.21 | +15,269.84% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $1.68 | +1,691.04% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.79 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $32.30 | +2.17% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $9.90 | +687.88% | 1 | Mar 24, 2017 |
Travere Therapeutics
Sep 10, 2025
Reiterates: Buy
Price Target: $47
Current: $25.70
Upside: +82.91%
Lexicon Pharmaceuticals
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.11
Upside: +260.36%
Tenaya Therapeutics
Sep 2, 2025
Reiterates: Buy
Price Target: $5
Current: $1.30
Upside: +284.62%
Neuphoria Therapeutics
Aug 26, 2025
Reiterates: Buy
Price Target: $21
Current: $14.22
Upside: +47.73%
Krystal Biotech
Aug 22, 2025
Reiterates: Buy
Price Target: $240
Current: $138.88
Upside: +72.81%
Lisata Therapeutics
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $2.25
Upside: +566.67%
Fortress Biotech
Aug 21, 2025
Maintains: Buy
Price Target: $26 → $17
Current: $3.74
Upside: +354.55%
Celldex Therapeutics
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $25.41
Upside: +65.29%
BiomX
Aug 20, 2025
Reiterates: Buy
Price Target: $15
Current: $0.48
Upside: +3,057.89%
Viking Therapeutics
Aug 19, 2025
Reiterates: Buy
Price Target: $102
Current: $26.26
Upside: +288.42%
Aug 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.41
Upside: +729.88%
Aug 13, 2025
Reiterates: Buy
Price Target: $16
Current: $7.64
Upside: +109.42%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $9.63
Upside: +211.53%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $6.50
Upside: +53.85%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.32
Upside: -
Jul 11, 2025
Maintains: Buy
Price Target: $77 → $24
Current: $6.31
Upside: +280.35%
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $1.21
Upside: +974.38%
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $14.67
Upside: +186.30%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.42
Upside: +478.51%
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $64.72
Upside: -18.11%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.66
Upside: +140.96%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.29
Upside: +597.67%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.38
Upside: +955.41%
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $2.76
Upside: +480.76%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $5.09
Upside: +17.88%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $3.96
Upside: +556.57%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $2.05
Upside: +387.80%
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $5.49
Upside: +537.52%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.75
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $36.33
Upside: +186.30%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.03
Upside: +197.16%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.89
Upside: +799.47%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $13.58
Upside: +135.64%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $3.42
Upside: +367.84%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $11.84
Upside: +2,011.49%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.73
Upside: +1,132.88%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.91
Upside: +844.88%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $8.27
Upside: +383.68%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $3.54
Upside: +577.97%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $52.36
Upside: +129.18%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $10.84
Upside: +47.60%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.22
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $6.35
Upside: +388.19%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $1.63
Upside: +636.20%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.86
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $14.88
Upside: +148.59%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.61
Upside: +583.23%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $37.25
Upside: +53.02%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.60
Upside: +1,150.00%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.18
Upside: +1,046.79%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $2.98
Upside: +738.93%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.53
Upside: +6,435.95%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.91
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $0.21
Upside: +15,269.84%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $1.68
Upside: +1,691.04%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.79
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $32.30
Upside: +2.17%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $9.90
Upside: +687.88%